screen_detected_DCIS__The_LORIS_Trial___May__20_2015_for_SRO.pdf (263.03 kB)
Addressing overtreatment of screen detected DCIS; the LORIS trial
journal contribution
posted on 2023-06-08, 22:25 authored by Adele Francis, Jeremy Thomas, Lesley FallowfieldLesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young, Lucinda Billingham, David Dodwell, Andrew Hanby, Sarah E Pinder, Andrew Evans, Malcolm Reed, Valerie JenkinsValerie Jenkins, Lucy Matthews, Maggie Wilcox, Patricia Fairbrother, Sarah Bowden, Daniel ReaAbstract Overdiagnosis, and thus overtreatment, are inevitable consequences of most screening programmes; identification of ways of minimising the impact of overdiagnosis demands new prospective research, in particular the need to separate clinically relevant lesions that require active treatment from those that can be safely left alone or monitored and only need treated if they change characteristics. Breast cancer screening has led to a large increase in ductal carcinoma in situ (DCIS) diagnoses. This is a widely heterogeneous disease and most DCIS detected through screening is of high cytonuclear grade and therefore likely to be important clinically. However, the historic practice of surgical treatment for all DCIS is unlikely to be optimal for lower risk patients. A clearer understanding of how to manage DCIS is required. This article describes the background and development of ‘The low risk’ DCIS trial (LORIS), a phase III trial of surgery versus active monitoring. LORIS will determine if it is appropriate to manage women with screen detected or asymptomatic, low grade and intermediate grade DCIS with low grade features, by active monitoring rather than by surgical treatment.
Funding
LORIS; G1317; NIHR Health Technology Assessment Programme; 11/36/16
History
Publication status
- Published
File Version
- Accepted version
Journal
European Journal of CancerISSN
0959-8049Publisher
ElsevierExternal DOI
Issue
16Volume
51Page range
2296-2303Department affiliated with
- Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2015-09-07First Open Access (FOA) Date
2016-07-17First Compliant Deposit (FCD) Date
2015-09-07Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC